Warham Lance Martin (Founding Manager) received his PhD in Biochemistry from California Institute of Technology in 2001. For his thesis, he solved the x-ray crystal structure of the neonatal Fc receptor in complex with its Fc ligand. He was a postdoctoral researcher at the Biochemistry Department at the Stanford University School of Medicine from 2002 through 2008, where he developed the technology central to Martin-Protean.